Display Settings:

Format

Send to:

Choose Destination
Crit Care. 2012 Jun 29;16(3):135. [Epub ahead of print]

Tranexamic acid: less bleeding and less thrombosis?

Author information

  • 1Department of Thrombosis and Vascular Biology, Rayne Institute, 4th Floor, Lambeth Wing, St, Thomas' Hospital, Westminster Bridge Road, London SE1 7EH, UK. Beverley.Hunt@gstt.nhs.uk.

Abstract

ABSTRACT: The early administration of tranexamic acid (TXA) to bleeding trauma patients reduces all-cause mortality without increasing the risk of vascular occlusive events. Indeed, the risk of arterial thrombosis appears to be reduced with TXA. In this commentary we hypothesize that TXA has an antithrombotic effect and explore potential mechanisms. These include inhibition of the inflammatory effects of plasmin, effects on platelets and effects on factors V and VIII. If proven, these antithrombotic effects would have major implications for the systemic use of TXA in surgical patients, where TXA has been clearly shown to reduce bleeding.

PMID:
22748073
[PubMed - as supplied by publisher]
PMCID:
PMC3580652
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Write to the Help Desk